← Evidence map

ReviewFrontiers in pharmacology2021

The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy.

Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33953675